Cynata Therapeutics Limited ( OTCPK:CYYNF) Discusses Clinical Trial Progress and Corporate Developments Including GVHD, Osteoarthritis, and Kidney Transplantation November 5, 2025 8:30 PM EST ...

Primary glomerular diseases in children and young adults can cause rapid kidney function decline, increasing lifetime risk of ...

Thepatent relates to methods of administering therapeutically effective amounts of isolated allogeneic mesenchymal stem cells (MSCs) to patients ...

PHILADELPHIA—Regional anesthesia—typically with a spinal or epidural block—has long been favored for cesarean births due in part to concerns about the ...

Development of a novel RNA biomarker for prostate cancer detection using seminal fluid and mismatched opioid prescriptions following urologic surgery are among the topics being presented by UCSF ...

The hazard ratio (HR) for the primary endpoint was (3.84, p = 0.0009) in the first month The Prolocor pFCG™ test has the ...

Experts discuss the crisis in India's psychology profession post-NEP 2020, highlighting confusion and potential impacts on ...

U.S. guidelines started discouraging prophylactic low-dose aspirin for adults over 70 in 2019. The U.S. Preventive Services ...

HOUSTON -- A culturally tailored intervention that included dietary tips and other recommendations helped modestly reduce ...

HUNTSVILLE, ALABAMA / ACCESS Newswire / November 13, 2025 / Curiteva, Inc. a privately held manufacturing and technology ...

Researchers have found in a new study that Perioperative factors like age, gender, smoking, education, and pre-hospital delay ...